AGBL2 and rheumatoid arthritis: In order better to understand if S-calprotectin is correlated with clinically used markers to define subgroups of RA, we performed sub-analyses of RA patients positive or negative for anti-CCP2 (Table 2) and positive or negative for RF (Table 3).